Ultimately, the goal is to strike a balance between the benefits of longevity and practicality while developing interventions for aging and health that are both accessible and sustainable
They work by mimicking the GLP-1 hormone produced in the intestine, which stimulates insulin release, reduces glucagon, slows gastric emptying, and promotes feelings of fullness
1 Patients with additional cardiovascular risk factors (CVRF), such as hypertension and dyslipidemia, are especially vulnerable to vision-threatening sequelae including ION
The free PDF gives you 3 starter days to test the rhythm
CJC-1295 (without DAC/Mod GRF 1-29): Shorter-acting version for more precise control of GH pulses
Regulatory and Policy Implications: The prominence of GLP-1 drugs may necessitate revisiting and revising healthcare policies, ensuring they are aligned with the latest scientific evidence and societal needs